ReviewFEMS yeast research2025
Harnessing yeasts for sustainable succinic acid production: advances in metabolic engineering and biorefinery integration.
Review in FEMS yeast research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- ExploringApplied and environmental microbiology · 2026Article
- Perspectives for Advancing Biotechnological Succinic Acid Production.Microbial biotechnology · 2026Review
- Biotechnological applications of D-xylose-fermenting autochthonous yeasts in lignocellulosic biorefineries.Biotechnology for biofuels and bioproducts · 2026Review
- Metabolic Engineering of Yeasts: A Key Cell Factory Platform for Advanced Biomanufacturing.Journal of fungi (Basel, Switzerland) · 2025Article
- Yeast-a handy multitool in your research: a report from ISSY38.FEMS yeast research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This review highlights the potential of Yarrowia lipolytica and other yeasts as sustainable producers of bio-based succinic acid (SA), a key platform chemical with applications in bioplastics, solvents, and pharmaceuticals. Recent advances in metabolic engineering have substantially improved SA titers, yields, and productivities in yeasts. These improvements were achieved by reconstructing biosynthetic pathways, disrupting gene involved in side-metabolism and/or expressing heterologous genes involved in critical metabolic functions. The use of renewable feedstocks, including crude glycerol, agricultural residues, food waste hydrolysates, and industrial by-products, has shown promise in reducing both production costs and environmental impacts. Innovative downstream separation techniques, such as in situ extraction, membrane filtration, and crystallization, further contribute to process sustainability. Integrating yeast-based SA production into circular biorefineries and adopting continuous production systems are promising strategies for enhancing economic feasibility and minimizing ecological footprints. Although challenges related to scale-up and process integration persist, ongoing advancements in genetic engineering and bioprocessing technologies position yeast-based processes as a viable route for sustainable, large-scale bio-based SA production within a circular bioeconomy framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.